Management of Small Renal Masses:
What is the Best Management Option in
This Case?
Part 1: The Role of Radical Nephrectomy in the Management or SRM
Part 2: Partial Nephrectomy
Part 3: Thermal Ablation
Part 4: How Lethal are SRMs? The Role of Active Surveillance
Release Date: January 21, 2009
Expiration Date: January 21, 2010
 |
||
|
How to Obtain AMA PRA
|
|
 |
||
Estimated Time of Completion: 1 hour
Description
The management of small renal masses has continued to evolve in recent years with the introduction of thermal ablative techniques, more sophisticated surgical techniques as well as the understanding that there are a group of patients that have more indolent diseases that may be safely observed. The risks and benefits of each of these approaches will be discussed, including the risk of local and metastatic progression. Lastly, appropriate selection is paramount to successfully implementing any approach and this will be discussed in the context of management of small renal masses.
Objectives
At the conclusion of this activity, the participant will be able to:
- Contrast the benefits and pitfalls of specific management options for patients that present with an incidental renal mass, including radical nephrectomy, partial nephrectomy, energy ablation, and active surveillance.
- Discuss the potential morbidity associated with active surveillance strategies, including the risk of local and metastatic progression.
- Explain issues of patient selection for appropriate management for a small renal mass.
Target Audience
This activity is directed to medical oncologists and urologists.
Accreditation
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association Council on Continuing Medical Education for Category 2 credit.
Activity Director(s)
| Brian Rini, MD Taussig Cancer Institute Cleveland Clinic Cleveland, OH |
Planning Committee
| Thomas Hutson, D.O., PharmD. Texas Oncology, PA Baylor Sammons Cancer Center Dallas, TX |
Christopher Wood, M.D., FACS M.D. Anderson Cancer Center Houston, TX |
Faculty
| Debra Gervais, MD Massachusetts General Hospital Boston, MA |
Peter Pinto, MD National Cancer Institute Bethesda, MD |
| Simon Tanguay, MD Montreal General Hospital Montreal, QC, Canada |
Robert Uzzo, MD Fox Chase Cancer Center Philadelphia, PA |
Faculty Disclosure
In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty have indicated that they may have a relationship, which in the context of their presentation(s), could be perceived as a potential conflict of interest:
| Debra A.Gervais, MD | |||
| Teaching & Speaking; Research Grant: |
Convidien | ||
| Thomas Hutson, MD | |||
| Consulting; Teaching & Speaking; Membership on advisory committee or
review panels: |
Bayer; Pfizer; Wyeth | ||
| Independent Contractor: | Bayer; GSK; Pfizer; Wyeth | ||
| Brian Rini, MD | |||
| Consulting; Membership on advisory committee or review panels: | Genentech; Novartis; Pfizer; Wyeth | ||
| Christopher Wood, MD | |||
| Consulting; Teaching & Speaking: | Ethicon; Pfizer | ||
The following faculty has indicated he/she has no relationship which, in the context of their presentation(s), could be perceived as a potential conflict of interest:
Peter Pinto, M.D.
Simon Tanguay, M.D.
Robert G. Uzzo, M.D., FACS
This CME activity was produced by The Cleveland Clinic Foundation
Center for Continuing Education and UNITECH Communications®.
